RACHEL BOETTCHER: Open Payments
NPI 1801544580 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,644 in 46 payments from 20 companies in 2025. Trend: 2023 $803 · 2024 $1,453 · 2025 $1,644
Food & beverage: $1,644
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 6 | $235 |
| Alnylam Pharmaceuticals Inc. | 3 | $199 |
| Koya Medical, Inc. | 7 | $186 |
| Actelion Pharmaceuticals US, Inc. | 3 | $178 |
| BridgeBio Pharma, Inc. | 2 | $168 |
| CVRx, Inc. | 1 | $150 |
| United Therapeutics Corporation | 4 | $110 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $58 |
| Boston Scientific Corporation | 3 | $56 |
| Merck Sharp & Dohme LLC | 2 | $55 |
Products named: THORATEC HEARTMATE 3 LVAS IMPLANT KIT, KOYA MEDICAL, UPTRAVI, Attruby, AMVUTTRA, Barostim Neo System, Tyvaso, LifeVest.
Industry payments across TX — which companies pay providers there.
